Correlation Between Newhydrogen and MabCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Newhydrogen and MabCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Newhydrogen and MabCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Newhydrogen and MabCure, you can compare the effects of market volatilities on Newhydrogen and MabCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Newhydrogen with a short position of MabCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Newhydrogen and MabCure.

Diversification Opportunities for Newhydrogen and MabCure

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Newhydrogen and MabCure is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Newhydrogen and MabCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MabCure and Newhydrogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Newhydrogen are associated (or correlated) with MabCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MabCure has no effect on the direction of Newhydrogen i.e., Newhydrogen and MabCure go up and down completely randomly.

Pair Corralation between Newhydrogen and MabCure

Given the investment horizon of 90 days Newhydrogen is expected to under-perform the MabCure. But the pink sheet apears to be less risky and, when comparing its historical volatility, Newhydrogen is 11.14 times less risky than MabCure. The pink sheet trades about 0.0 of its potential returns per unit of risk. The MabCure is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  0.10  in MabCure on September 3, 2024 and sell it today you would lose (0.09) from holding MabCure or give up 90.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Newhydrogen  vs.  MabCure

 Performance 
       Timeline  
Newhydrogen 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Newhydrogen are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Newhydrogen may actually be approaching a critical reversion point that can send shares even higher in January 2025.
MabCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MabCure has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, MabCure is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Newhydrogen and MabCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Newhydrogen and MabCure

The main advantage of trading using opposite Newhydrogen and MabCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Newhydrogen position performs unexpectedly, MabCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MabCure will offset losses from the drop in MabCure's long position.
The idea behind Newhydrogen and MabCure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume